ADRENALINE DRIVE

Serial Number 87245670
Registration 5661994
702

Registration Progress

Application Filed
Nov 22, 2016
Under Examination
Jul 4, 2017
Approved for Publication
May 9, 2017
Published for Opposition
May 9, 2017
Registered
Jan 22, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-01-22)
Due: Jan 22, 2025 Overdue

Trademark Image

ADRENALINE DRIVE

Basic Information

Serial Number
87245670
Registration Number
5661994
Filing Date
November 22, 2016
Registration Date
January 22, 2019
Published for Opposition
May 9, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 14, 2025
Registration
Registered
Classes
005

Rights Holder

MAXIMUM HUMAN PERFORMANCE LLC

16
Address
165 CLINTON ROAD
WEST CALDWELL, NJ 07006

Ownership History

Prescott Ventures LLC

Original Applicant
16
Fairfax, VT

Prescott Ventures LLC

Owner at Publication
16
Fairfax, VT

MAXIMUM HUMAN PERFORMANCE LLC

New Owner After Publication #1
16
WEST CALDWELL, NJ

MAXIMUM HUMAN PERFORMANCE LLC

Original Registrant
16
WEST CALDWELL, NJ

Legal Representation

Attorney
Alison M. Caless

USPTO Deadlines

Next Deadline
1293 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-01-22)
Due Date
January 22, 2029
Grace Period Ends
July 22, 2029

Application History

43 events
Date Code Type Description
Feb 14, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 14, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 14, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Jan 22, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 22, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 18, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 17, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 8, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Dec 7, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Dec 7, 2018 IUAF S USE AMENDMENT FILED
Jun 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2018 EX2G S SOU EXTENSION 2 GRANTED
Jun 28, 2018 EXT2 S SOU EXTENSION 2 FILED
Jun 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
May 7, 2018 WOAG I WITHDRAWAL OF ATTORNEY GRANTED
May 7, 2018 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED
May 7, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 17, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2018 EX1G S SOU EXTENSION 1 GRANTED
Jan 9, 2018 NREV E NOTICE OF REVIVAL - E-MAILED
Jan 9, 2018 PROA I TEAS PETITION TO REVIVE RECEIVED
Jan 9, 2018 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 9, 2018 PETG O PETITION TO REVIVE-GRANTED
Jan 5, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 4, 2018 EXT1 S SOU EXTENSION 1 FILED
Jan 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 4, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 9, 2017 PUBO A PUBLISHED FOR OPPOSITION
Apr 19, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2017 GNRT F NON-FINAL ACTION E-MAILED
Mar 7, 2017 CNRT R NON-FINAL ACTION WRITTEN
Mar 7, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2017 DOCK D ASSIGNED TO EXAMINER
Nov 30, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Vitamin supplements
First Use Anywhere: 20180100
First Use in Commerce: Jul 5, 2018

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ADRENALINE"